Watching Incyte; Traders Circulate Research Report From Unemon Suggesting Novartis Emerges As The Ideal Acquirer, Says "Would Not Be Surprised To See A $105-$110 Deal In The Coming Weeks"
Watching Incyte; Traders Circulate Research Report From Unemon Suggesting Novartis Emerges As The Ideal Acquirer, Says "Would Not Be Surprised To See A $105-$110 Deal In The Coming Weeks"
關注因塞特；交易者傳播來自Unemon的研究報告，建議諾華成爲理想的收購者，並表示「不會驚訝在未來幾周看到105 - 110美元的交易」
Watching Incyte; Traders Circulate Research Report From Unemon Suggesting Novartis Emerges As The Ideal Acquirer, Says "Would Not Be Surprised To See A $105-$110 Deal In The Coming Weeks"
看着Incyte；交易員發佈Unemon的研究報告，表明諾華將成爲理想的收購者，他們表示 「在未來幾周內看到105-110美元的交易不會感到驚訝」
資訊熱榜
更新時間